Global Antidiabetics Market Anticipated to Generate a Revenue of $148.3 Billion and Grow at a CAGR of 11.1% during the forecast period 2020-2027 | Analysis by Research Dive
October 31, 2022 09:01 ET
|
Research Dive
New York, USA, Oct. 31, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global antidiabetics market is envisioned to garner a revenue of $148.3 billion by 2027,...
The Worldwide Smart Insulin Pens Industry is Expected to Reach $298.9 Million by 2030
October 25, 2022 05:48 ET
|
Research and Markets
Dublin, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The "Smart Insulin Pens Market By Type, By Usability, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
Smart Insulin Pens Global Market to Reach $214.05 Million by 2027 at a CAGR of 12.81%
October 11, 2022 08:48 ET
|
Research and Markets
Dublin, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The "Smart Insulin Pens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Insulin Delivery Devices Market Report 2022: A $39.37 Billion Market by 2030 - Growing Significance of Home Infusion Therapy for Diabetes Treatment
October 04, 2022 07:23 ET
|
Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The "Insulin Delivery Devices Market Research Report: By Type, Distribution Channel, End Use - Global Market Demand Forecast to 2030" report has been added...
Safety Pen Needles Market in North America to Exceed Value of US$ 1.17 Bn by 2031, States TMR Analysis
September 30, 2022 09:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The safety pen needles market in North America is prognosticated to surpass a value of US$...
Global Insulin Drug and Delivery Technology Markets Report 2022-2027 With Profiles of Key Manufacturers - Sanofi, Eli Lilly, Novo Nordisk, Medtronic, Roche, BD & Co, Ypsomed and Braun
September 15, 2022 04:58 ET
|
Research and Markets
Dublin, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The "Global Markets for Insulin Drug and Delivery Technologies" report has been added to ResearchAndMarkets.com's offering. The current report will...
Global Smart Insulin Pens Market Report 2022: A $120 Million Market by 2026 - Long-term Forecasts to 2031
September 09, 2022 04:38 ET
|
Research and Markets
Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Smart Insulin Pens Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global smart insulin pens market is...
Needle-Free Injection System Market Worth USD 411.31 Million by 2028 at 17.7% CAGR Global Analysis by Product (Fillable Needle Free Injectors, Prefilled Needle Free Injectors)
September 01, 2022 06:31 ET
|
The Insight Partners
New York, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Needle-Free Injection System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph
August 30, 2022 06:45 ET
|
Seraxis, Inc.
GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) -- The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an...
Insights on the Rapid Acting Insulin Global Market to 2027 - by Product, Indication, Distribution Channel and Region
August 22, 2022 08:43 ET
|
Research and Markets
Dublin, Aug. 22, 2022 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...